Pharmaceutical / Drug Definition :
Thought to exert partial agonist activity at central dopamine D2 and type 1A serotonin (5-HT1A) receptors and antagonistic activity at serotonin 5-HT2A receptors. Also has alpha-adrenergic and histamine1-blocking properties.
In the United States, Aripiprazole is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Aripiprazole.
FDA Label Requirements and Exceptions
FDA Import Information
Aripiprazole (Aripiprazole Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Aripiprazole (Aripiprazole Suppliers)
- Processors Aripiprazole
- Repackers Aripiprazole
- Relabelers Aripiprazole
- Exporters Aripiprazole
- Importers Aripiprazole
For more information about Aripiprazole, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.